Status:
ENROLLING_BY_INVITATION
Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
HIV Infections
Substance Use Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The current protocol aims to enroll up to 806 participants from 8 study sites in a clinic-supported intervention which will connect them to Vivent Health care team and a cohort of peer mentors for a y...
Detailed Description
This protocol describes the implementation phase of a 5-year NIH-funded research project designed to evaluate the effectiveness of an innovative clinic-level intervention featuring an evidence-based, ...
Eligibility Criteria
Inclusion
- Able to read, write and speak English
- Receives HIV Disease Care at Vivent Health
- At risk for poor engagement in HIV care, as evidenced by any one of the following:
- Prior missed clinic visits
- Poor adherence to medical treatment defined as 2 or more missed doses of medication in a month
- Unhealthy alcohol or other substance use, as evidenced by a diagnosis of substance use disorder on the patient's problem list, a prior referral to alcohol or substance abuse services, or answering "yes" to one or both of the following screening questions:
- Has drinking alcohol or using drugs (including marijuana) ever caused problems in your life, such as damaging relationships, causing you to not meet obligations at work, or getting in trouble with the law?
- Are you currently participating in any treatment or counseling because of problems caused by drug use? This can include groups like N. A., or one-on-one interaction with a doctor or therapist.
Exclusion
- Individuals who do not currently have a smartphone or are unwilling to obtain a smartphone will not be able to participate in this study.
- People who are unwilling to download and activate the Connections app.
- People with cognitive or other impairment that precludes the capacity to consent.
Key Trial Info
Start Date :
December 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
806 Patients enrolled
Trial Details
Trial ID
NCT06109571
Start Date
December 4 2023
End Date
March 1 2027
Last Update
September 16 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Vivent Health Clinic
Denver, Colorado, United States, 80246
2
Vivent Health Clinic
Kansas City, Missouri, United States, 64130
3
Vivent Health Clinic
St Louis, Missouri, United States, 63103
4
Vivent Health Clinic
Austin, Texas, United States, 78752